Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drugMendeley Data

Tenofovir alafenamide (TAF) is currently administered orally to patients for treatment of chronic hepatitis B virus infection and as a part of a combination therapy for human immunodeficiency virus (HIV) infection. A long-acting delivery system could provide several advantages as a formulation strat...

Full description

Saved in:
Bibliographic Details
Main Authors: Sungmin Jung, Jack Bufton, Zeqing Bao, Wonjoon Cho, Dean Aguiar, Christine Allen
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Data in Brief
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352340924011442
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576452721115136
author Sungmin Jung
Jack Bufton
Zeqing Bao
Wonjoon Cho
Dean Aguiar
Christine Allen
author_facet Sungmin Jung
Jack Bufton
Zeqing Bao
Wonjoon Cho
Dean Aguiar
Christine Allen
author_sort Sungmin Jung
collection DOAJ
description Tenofovir alafenamide (TAF) is currently administered orally to patients for treatment of chronic hepatitis B virus infection and as a part of a combination therapy for human immunodeficiency virus (HIV) infection. A long-acting delivery system could provide several advantages as a formulation strategy for this drug including improved patient adherence, convenience, more consistent drug levels and potentially fewer side effects. To date, the vast majority of polymer-based long-acting delivery systems have been prepared from poly(lactide-co-glycolide) [1]. To expand the range of polymers available for use, cross-linkable allyl functionalized, polyester copolymers were considered for preparation of disc-shaped, implantable delivery systems for TAF. The physico-chemical properties of the implants were evaluated including thermal and spectral properties as well as in vitro stability. Subsequently the discs were loaded with TAF via a swelling-equilibrium approach and the discs were further characterized including, TAF loading and in vitro drug release. This dataset shows the potential of using these polymeric materials as a sustained delivery platform for TAF. The dataset is freely available on Mendeley Data.
format Article
id doaj-art-03718f9b6f554574b5276df8508de8c6
institution Kabale University
issn 2352-3409
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Data in Brief
spelling doaj-art-03718f9b6f554574b5276df8508de8c62025-01-31T05:11:26ZengElsevierData in Brief2352-34092025-02-0158111182Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drugMendeley DataSungmin Jung0Jack Bufton1Zeqing Bao2Wonjoon Cho3Dean Aguiar4Christine Allen5Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, CanadaLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, CanadaLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, CanadaLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, CanadaPendant Inc, JLabs Toronto, 661 University Avenue, Suite 1300, Toronto M5G 0B7, CanadaLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, Canada; Department of Chemical Engineering & Applied Chemistry, University of Toronto, Toronto, ON M5S 3E5, Canada; Corresponding author at: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, Canada.Tenofovir alafenamide (TAF) is currently administered orally to patients for treatment of chronic hepatitis B virus infection and as a part of a combination therapy for human immunodeficiency virus (HIV) infection. A long-acting delivery system could provide several advantages as a formulation strategy for this drug including improved patient adherence, convenience, more consistent drug levels and potentially fewer side effects. To date, the vast majority of polymer-based long-acting delivery systems have been prepared from poly(lactide-co-glycolide) [1]. To expand the range of polymers available for use, cross-linkable allyl functionalized, polyester copolymers were considered for preparation of disc-shaped, implantable delivery systems for TAF. The physico-chemical properties of the implants were evaluated including thermal and spectral properties as well as in vitro stability. Subsequently the discs were loaded with TAF via a swelling-equilibrium approach and the discs were further characterized including, TAF loading and in vitro drug release. This dataset shows the potential of using these polymeric materials as a sustained delivery platform for TAF. The dataset is freely available on Mendeley Data.http://www.sciencedirect.com/science/article/pii/S2352340924011442PharmaceuticsLong-acting therapeuticsPolymersTenofovir alafenamideSustained release
spellingShingle Sungmin Jung
Jack Bufton
Zeqing Bao
Wonjoon Cho
Dean Aguiar
Christine Allen
Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drugMendeley Data
Data in Brief
Pharmaceutics
Long-acting therapeutics
Polymers
Tenofovir alafenamide
Sustained release
title Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drugMendeley Data
title_full Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drugMendeley Data
title_fullStr Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drugMendeley Data
title_full_unstemmed Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drugMendeley Data
title_short Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drugMendeley Data
title_sort data characterizing a panel of biodegradable cross linked polyester implants for sustained delivery of an anti viral drugmendeley data
topic Pharmaceutics
Long-acting therapeutics
Polymers
Tenofovir alafenamide
Sustained release
url http://www.sciencedirect.com/science/article/pii/S2352340924011442
work_keys_str_mv AT sungminjung datacharacterizingapanelofbiodegradablecrosslinkedpolyesterimplantsforsustaineddeliveryofanantiviraldrugmendeleydata
AT jackbufton datacharacterizingapanelofbiodegradablecrosslinkedpolyesterimplantsforsustaineddeliveryofanantiviraldrugmendeleydata
AT zeqingbao datacharacterizingapanelofbiodegradablecrosslinkedpolyesterimplantsforsustaineddeliveryofanantiviraldrugmendeleydata
AT wonjooncho datacharacterizingapanelofbiodegradablecrosslinkedpolyesterimplantsforsustaineddeliveryofanantiviraldrugmendeleydata
AT deanaguiar datacharacterizingapanelofbiodegradablecrosslinkedpolyesterimplantsforsustaineddeliveryofanantiviraldrugmendeleydata
AT christineallen datacharacterizingapanelofbiodegradablecrosslinkedpolyesterimplantsforsustaineddeliveryofanantiviraldrugmendeleydata